Last reviewed · How we verify
NCT04921735
An Observational Study of Cisatracurium 0.15 mg/kg in Young and Elderly (≥ 80 Years) Patients.
trial testing Cisatracurium in Onset Time of Cisatracurium in 60 participants. Completed in 19 December 2021.
19 December 2021
Quick facts
| Lead sponsor | Matias Vested |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 60 |
| Start date | 5 July 2021 |
| Primary completion | 19 December 2021 |
| Estimated completion | 19 December 2021 |
| Sites | 1 location across Denmark |
Drugs / interventions tested
- Cisatracurium (CISATRACURIUM) — full drug profile →
Conditions studied
- Onset Time of Cisatracurium — all drugs for Onset Time of Cisatracurium →
- Duration of Action of Cisatracurium — all drugs for Duration of Action of Cisatracurium →
- Intubation Conditions — all drugs for Intubation Conditions →
Sponsor
Matias Vested — full company profile →
Who can join
Adults 18 to 110, any sex, with Onset Time of Cisatracurium or Duration of Action of Cisatracurium. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this study is to determine the onset time, duration of action and effect on intubation conditions of cisatracurium 0.15 mg/kg in elderly patients with age ≥ 80 years and in young patients aged 18 - 40 years.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Comparison of onset time, duration of action, and intubating conditions after cisatracurium 0.15 mg/kg in young and elderly patients.
Vested M, Kristensen CM, Pape P, Vang M, et al · · 2022 · cited 5× · PMID 36344924 · DOI 10.1186/s12871-022-01881-5
Verify or expand the search:
- PubMed search for NCT04921735
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Cisatracurium
Trials testing the same drug.
- NCT07203287 — Risk of Acute Complications With Rocuronium vs Cisatracurium in Patients With Chronic Kidney Disease · Phase 4 · recruiting
- NCT07143799 — Scalp Block Versus General Anesthesia in Patients Undergoing Evacuation of Subdural Hematoma Via Burr Hole · NA · recruiting
- NCT06203405 — The Efficacy of P0.1-guided Sedation Protocol in Critically Ill Patients Receiving Invasive Mechanical Ventilation: A Ra · NA · recruiting
- NCT05760976 — Median Effective Dose of Cisatracurium for the Prevention of Fasciculation Caused by the Injection of Succinylcholine · NA · unknown
- NCT05310110 — Muscle Relaxants and Laryngeal Local Anesthetics for Laryngeal Mask Airway Insertion Decreasing Propofol in Elderly · NA · completed
Other Matias Vested trials
Trials by the same sponsor.
- NCT06406010 — Investigating the Effect of Pericapsular Nerve Group (PENG) Block on Postoperative Pain After Peri-acetabular Osteotomy · Phase 4 · recruiting
- NCT06409260 — Neuromuscular Monitoring in Children (6 Months - 2 Years) With Electromyography and Acceleromyography · NA · recruiting
- NCT06228092 — Neostigmine/Glyco-pyrrolate 50 Mikrogram/kg or Sugammadex 2 mg/kg for Reversal of Neuromuscular Blockade in Elderly Pati · Phase 4 · completed
- NCT05558137 — Mivacurium 0.2 mg/kg in Young (18 - 40 Years) and Elderly (= 80 Years) Patients · completed
- NCT04868409 — Intubating Conditions During Rapid Sequence Induction in Elderly With Either Suxamethonium 1.0 mg/kg or Rocuronium 1.0 m · Phase 4 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04921735 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Matias Vested
- Last refreshed: 26 January 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04921735.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing